Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Pediatric Respiratory Acidosis Medication

  • Author: Mithilesh K Lal, MBBS, MD, MRCP, FRCPCH; Chief Editor: Timothy E Corden, MD  more...
 
Updated: Jun 05, 2014
 

Medication Summary

Mechanical ventilation is the mainstay of therapy for respiratory failure associated with hypercapnia until the precipitating disease state can be reversed. Tromethamine (THAM) has been used to prevent and correct systemic or respiratory acidosis. Sodium bicarbonate (NaHCO3) is sometimes employed but should be administered with caution if used.

Next

Alkalinizing agents

Class Summary

Treatment of a concurrent metabolic acidosis or buffering the acidemia with a respiratory acidosis can be considered. In certain cases, THAM may be helpful.

Tromethamine (THAM)

 

THAM, also known as tris[hydroxymethyl]-aminomethane, is used to prevent and correct systemic or respiratory acidosis. It is a biologically inert weak base that can buffer excess carbon dioxide. It combines with hydrogen ions to form bicarbonate (HCO3–) buffer, as follows:

R-NH2 + CO2 + H2O = R-NH3 + HCO3

At 37°C, pKa is 7.8; therefore, THAM is a more effective buffer than NaHCO3– in the physiologic blood pH range. It is not protein bound and is distributed primarily in extracellular space. When protonated, THAM is excreted by the kidneys and acts as an osmotic diuretic. It is most appropriately administered as a short-term infusion during the therapeutic window to correct acute respiratory acidosis.

Previous
 
Contributor Information and Disclosures
Author

Mithilesh K Lal, MBBS, MD, MRCP, FRCPCH MRCP, MRCPCH, FRCPCH, Consultant Neonatologist, James Cook University Hospital, UK

Mithilesh K Lal, MBBS, MD, MRCP, FRCPCH is a member of the following medical societies: British Medical Association, Royal College of Physicians, Royal College of Paediatrics and Child Health, British Association of Perinatal Medicine, American Pediatric Society, Society for Pediatric Research, Neonatal Society, Nepal Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Ronald Litman, DO Professor of Anesthesiology and Pediatrics, University of Pennsylvania School of Medicine

Ronald Litman, DO is a member of the following medical societies: American Academy of Pediatrics, American Society of Anesthesiologists, Society for Pediatric Anesthesia

Disclosure: Nothing to disclose.

Margaret A Priestley, MD Associate Professor of Clinical Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania; Clinical Director, Pediatric Intensive Care Unit, The Children's Hospital of Philadelphia

Margaret A Priestley, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Chief Editor

Timothy E Corden, MD Associate Professor of Pediatrics, Co-Director, Policy Core, Injury Research Center, Medical College of Wisconsin; Associate Director, PICU, Children's Hospital of Wisconsin

Timothy E Corden, MD is a member of the following medical societies: American Academy of Pediatrics, Phi Beta Kappa, Society of Critical Care Medicine, Wisconsin Medical Society

Disclosure: Nothing to disclose.

Acknowledgements

G Patricia Cantwell, MD, FCCM Professor of Clinical Pediatrics, University of Miami, Leonard M Miller School of Medicine; Chief, Division of Pediatric Critical Care Medicine, Medical Manager, Urban Search & Rescue, South Florida TF-2, Medical Director, Holtz Children's Hospital Palliative Care Team, Medical Director, Tilli Kids – Pediatric Initiative of Hospice Care of SE Florida, Director, Pediatric Critical Care Transport, Holtz Children's Hospital/Jackson Memorial Hospital

G Patricia Cantwell, MD, FCCM is a member of the following medical societies: American Academy of Hospice and Palliative Medicine, American Academy of Pediatrics, American Heart Association, American Trauma Society, National Association of EMS Physicians, Society of Critical Care Medicine, and Wilderness Medical Society

Disclosure: Nothing to disclose.

Barry J Evans, MD Assistant Professor of Pediatrics, Temple University Medical School; Director of Pediatric Critical Care and Pulmonology, Associate Chair for Pediatric Education, Temple University Children's Medical Center

Barry J Evans, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

References
  1. Epstein SK, Singh N. Respiratory acidosis. Respir Care. 2001 Apr. 46(4):366-83. [Medline].

  2. Ramamoorthy C, Tabbutt S, Kurth CD, et al. Effects of inspired hypoxic and hypercapnic gas mixtures on cerebral oxygen saturation in neonates with univentricular heart defects. Anesthesiology. 2002 Feb. 96(2):283-8. [Medline].

  3. Goldstein B, Shannon DC, Todres ID. Supercarbia in children: clinical course and outcome. Crit Care Med. 1990 Feb. 18(2):166-8. [Medline].

  4. Makhoul IR, Bar-Joseph G, Blazer S, et al. Intratracheal pulmonary ventilation in premature infants and children with intractable hypercapnia. ASAIO J. 1998 Jan-Feb. 44(1):82-8. [Medline].

  5. Laffey JG, O'Croinin D, McLoughlin P, Kavanagh BP. Permissive hypercapnia--role in protective lung ventilatory strategies. Intensive Care Med. 2004 Mar. 30(3):347-56. [Medline].

  6. ARDS Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000. 342:1301-8. [Medline].

  7. Annane D, Orlikowski D, Chevret S, Chevrolet JC, Raphael JC. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database Syst Rev. 2007. (4):CD001941. [Medline].

  8. Brian JE. Carbon dioxide and the cerebral circulation. Anesthesiology. 1998 May. 88(5):1365-86. [Medline].

  9. Halpern P, Raskin Y, Sorkine P, Oganezov A. Exposure to extremely high concentrations of carbon dioxide: a clinical description of a mass casualty incident. Ann Emerg Med. 2004 Feb. 43(2):196-9. [Medline].

  10. Kiely DG, Cargill RI, Lipworth BJ. Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest. 1996 May. 109(5):1215-21. [Medline].

  11. Low JM, Gin T, Lee TW, Fung K. Effect of respiratory acidosis and alkalosis on plasma catecholamine concentrations in anaesthetized man. Clin Sci (Lond). 1993 Jan. 84(1):69-72. [Medline].

  12. Mas A, Saura P, Joseph D, et al. Effect of acute moderate changes in PaCO2 on global hemodynamics and gastric perfusion. Crit Care Med. 2000 Feb. 28(2):360-5. [Medline].

  13. Mazzeo AT, Spada A, Pratico C, et al. Hypercapnia: what is the limit in paediatric patients? A case of near-fatal asthma successfully treated by multipharmacological approach. Paediatr Anaesth. 2004 Jul. 14(7):596-603. [Medline].

  14. Thome UH, Carlo WA. Permissive hypercapnia. Semin Neonatol. 2002 Oct. 7(5):409-19. [Medline].

  15. Vavilala MS, Lee LA, Lam AM. Cerebral blood flow and vascular physiology. Anesthesiol Clin North America. 2002 Jun. 20(2):247-64. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.